DDR2 has been found to promote invasion in prostate (Yan et al., 2014), non-small cell lung (Kim et al., 2014), breast (Zhang et al., 2013), and metastatic melanoma (Poudel et al., 2015). Here, DDR2 is linked to metastatic melanoma.